HONBRIDGE (02528) announced its interim results, reporting a loss attributable to shareholders of HKD 8.53 million, a decrease of 73.8% year-on-year.
Hongqiao Group (02528) announced its interim results for the six months ended June 30, 2026, reporting revenue of HKD 61.678 million, a year-on-year increase of 298.26%; the loss attributable to equity holders of the company was HKD 8.53 million, a year-on-year decrease of 73.8%; the loss per share was HKD 0.06.
HONBRIDGE (02528) announced its interim results for the six months ended June 30, 2026, with revenues of HKD 61.678 million, an increase of 298.26% year-on-year; loss attributable to owners of the company was HKD 8.53 million, a decrease of 73.8% year-on-year; loss per share was HKD 0.06.
Related Articles
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."
Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.
Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."
Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.
Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
RECOMMEND
